Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001493152-20-013713

Options or other derivatives

  • Director acquired 145,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Buell Jennifer Director 2020-07-18 Grant or award · PTIX Common stock Options +145,000 $1.75 $253,750 145,000 D
Loading xslF345X03/ownership.xml…